https://www.selleckchem.com/pr....oducts/yap-tead-inhi
5 person-years of follow-up (rate, 7.99/100 person-years). The median time to first reinfection (interquartile range) was 128 (85.25-202.5) days. Before July 1, 2018, 72 patients accessed DAAs over 3.7 years; after Medicaid DAA restrictions were lifted, 109 patients accessed DAAs over 1.3 years. The Prior Authorization (PA) process requires many steps, differing across 11 RI insurers, taking 45-120 minutes per patient. DAA treatment was effective among a marginalized population in an urban colocated OAT/HCV progr
Like
Comment
Share
